Welcome back to The Trip Report Podcast, a production of Beckley Waves, a Psychedelic Venture Studio. Today, I am speaking with Joanna Kempner, PhD, a medical sociologist with deep expertise in the healthcare system’s approach—and shortcomings—to treating chronic illness....
Relational. Experiential. Energetic. Metabolic....
Welcome back to The Trip Report Podcast, a production of Beckley Waves, a Psychedelic Venture Studio. Today, in honor of PTSD Awareness Month, we are speaking with filmmaker Brandon Kapelow, the writer and director of the short film titled An Act of Service...
The collective sentiment following the now infamous FDA ADCOM meeting about Lykos Therapeutic’s Midomafetamine Assisted-Therapy (AKA MDMA Assisted-Therapy) might be described as ‘on the knife’s edge’ or ‘hanging in the balance’ as we await the final verdict from the FDA on August 11th....
Welcome back to The Trip Report Podcast, a production of Beckley Waves, a Psychedelic Venture Studio Today, we have the honor of speaking with distinguished neuroscientist and researcher of consciousness, Christof Koch, Ph.D. Christof is the Chief Scientist of the...
“We already have evidence-based treatments for PTSD”...
Welcome back to The Trip Report Podcast, a production of Beckley Waves, a Psychedelic Venture Studio. Today, I am speaking with Manesh Girn, Ph.D, a prominent researcher and science communicator in the field of psychedelics and neuroscience. Manesh is a postdoctoral researcher at UCSF in...
The psychedelic field lost a great friend, colleague—and I would say mentor—as Ken Jordan, co-founder and Editorial Director of Lucid New, passed away unexpectedly.Ken was also the founder of Reality Sandwich, Evolver, and The Alchemist’s Kitchen—media platforms that shared the attributes of sincerity, curiosity and...
Welcome back to The Trip Report Podcast, a production of Beckley Waves, a Psychedelic Venture Studio.Today, I am speaking with Dennis Walker, AKA the Mycopreneur.I don’t know about you, but I am always flummoxed by the seriousness of the discourse among stakeholders in the ‘psychedelic...
This week, the company formerly known as MAPS PBC—Lykos Therapeutics—announced that the FDA will start the review process for MDMA-Assisted Therapy in June. From the Lykos Press Release:on June 4, 2024, the U.S. Food and Drug Administration’s (“FDA”) Psychopharmacologic Drugs Advisory Committee (“PDAC”) will review data...